Live Biotherapeutic to Augment Response to Immunotherapy
A novel strain of E. Coli capable of inducing TH17 T cells to improve immune response
Published: 29th October 2019

IP Status
- Patent application submitted
A novel strain of E. Coli capable of inducing TH17 T cells to improve immune response